Blopress and Fosamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Blopress (candesartan cilexetil) and Fosamax (alendronate sodium). Common drug interactions include upper respiratory tract inflammation among females and jaundice among males.

The phase IV clinical study analyzes what interactions people have when they take Blopress and Fosamax. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.

What is Fosamax?

Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.

On Jul, 14, 2026

65 people who take Blopress and Fosamax together, and have interactions are studied.

What are the common drug interactions of Blopress and Fosamax, by gender? *:

female:

Upper respiratory tract inflammation
Venous thrombosis (blood clot (thrombus) that forms within a vein)
Fungal infection
Poor dental condition
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Nausea (feeling of having an urge to vomit)
Osteomyelitis (infection of bone)
Vomiting
Osteonecrosis (death of bone)
Blood lactate dehydrogenase increased

male:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Blood creatine phosphokinase increased
Inappropriate antidiuretic hormone secretion
Skin ulcer
Wound infection
Asthenia (weakness)
Decreased appetite
Jaw disorder (jaw disease)

What are the common drug interactions of Blopress and Fosamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal wall haematoma (abdominal wall blood clotting)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Sudden death

50-59:

Neuromyopathy (disease of both muscles and nerves)
Oedema (fluid collection in tissue)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)
Pulmonary embolism (blockage of the main artery of the lung)
Sensitivity of teeth
Sick sinus syndrome (a collection of heart rhythm disorders)
Skin cancer
Skin disorder (skin disease)
Spinal osteoarthritis (joint cartilage loss in spine)

60+:

Vomiting
Nausea (feeling of having an urge to vomit)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Osteonecrosis (death of bone)
Blood creatine phosphokinase increased
Chest pain
Chills (felling of cold)
Dehydration (dryness resulting from the removal of water)
Gingival swelling (gums swelling)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 27.69%
Gastritis (inflammation of stomach): 14 people, 21.54%
Insomnia (sleeplessness): 7 people, 10.77%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 6 people, 9.23%
Type 2 Diabetes: 4 people, 6.15%
Spinal Osteoarthritis (joint cartilage loss in spine): 4 people, 6.15%
Pain: 4 people, 6.15%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Blopress and Fosamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously